Association of vitamin D status and COVID-19 infection
Authors:
J. Richter 1; V. Větvička 2; V. Král 1; P. Šíma 3; I. Stiborová 1
Authors‘ workplace:
Zdravotní ústav se sídlem v Ústí nad Labem, Centrum imunologie a mikrobiologie, Vedoucí: Ing. Eduard Ježo
1; Department of Pathology and Laboratory Medicine, University of Louisville, KY, USA, Chairman: Eyas M. Hattab, MD, MBA
2; Akademie věd ČR, Mikrobiologický ústav, Laboratoř imunoterapie, Praha, Vedoucí: Dr. Luca Vannucci, M. D., PhD.
3
Published in:
Prakt. Lék. 2023; 103(1): 10-14
Category:
Of different specialties
Overview
The COVID-19 outbreak marks a global public health crisis. Therefore, consideration is given to preventative measures that could contribute to reducing the risk of infection and positively influence the course of the disease. Attention is currently being paid to the use of nutraceuticals, mainly vitamin D, minerals and beta glucans. In this study, we monitor the relationship of vitamin D levels in immunodeficient patients to the risk of developing COVID-19. In a set of 71 patients, we find gradation of disease onset and progression in patients with values less than 30 ng/mL. In individuals with vitamin D levels above 40 ng/mL, we find a high level of protection, and a beneficial course of clinical manifestation stemming from the application of minerals and beta glucans.
Keywords:
COVID-19 – vitamin D – beta glucan – minerals
Sources
1. Alexander J, Tinkov A, Strand TA, et al. Early nutritional interventions with zinc, selenium and vitamin D for raising anti-viral resistence against progressive COVID-19. Nutrients 2022; 12(8): 2358.
2. Alagawany M, Attia YA, Farag MR, et al. The strategy of boosting the immune system under the COVID-19 pandemic. Front Vet Sci 2021; 7: 570748.
3. Ali N. Role of vitamin D in preventing of COVID-19 infection, progression and severity. J Infect Public Health 2020; 13(10): 1373–1380.
4. Amrein K, Scherkl M, Hoffmann M, et al. Vitamin D deficiency 2.0: an update on the current status worldwide. Eur J Clin Nutr 2020; 74(11): 1498–1513.
5. Aranow, C. Vitamin D and the immune system. J Investig Med 2011; 59(6): 881–886.
6. Bobryshev YV. Vitamin D suppresses immune reactions in atherosclerosis, affecting regulatory t cells and dendritic cell function. Arterioscler Thromb Vasc Biol 2010; 30(12): 2317–2319.
7. Calder PC. Nutrition, immunity and COVID-19. BMJ Nutr Prev Health 2020; 3(1): 74–92.
8. Chowdhury MA, Hossain N, Kashwm MA, et al. Immune response in COVID-19: a review. J Infect Public Health 2020; 13(11): 1619–1629.
9. Crane-Godreau MA, Clem KJ, Payne P, et al. Vitamin D deficiency and air pollution exacerbate covid-19 through suppression of antiviral peptide LL37. Front Public Health 2020; 8: 232.
10. Crespi B, Alcock J. Conflicts over calcium and the treatment of Covid-19. Evol Med Public Health 2020; 9(1): 149–156.
11. Demir M, Demir F, Aygun H. Vitamin D deficiency is associated with COVID-19 positivity and severity of the disease. J Med Virol 2021; 93(5): 2992–2999.
12. Dramé M, Cofais C, Hentzien M, et al. Relation between vitamin D and Covid-19 in aged people: a systematic review. Nutrients 2021; 13(4): 1339.
13. Fisher SA, Rahimzadeh M, Brierley C, et al. The role of vitamin D in increasing ciculating T regulatory cell numbers and modulating T regulatory cell phenotypes in patients with inflammatory disease or in healthy volunteers: a systematic review. PLoS One 2019; 14(9): e0222313.
14. Garvin MR, Alvarez C, Miller JI, et al. A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm. Elife 2020; 9: e59177.
15. Grant WB, Lahore H, McDonnell SH, et al. Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths. Nutrients 2020; 12(4): 988.
16. Gröber U, Kisters K. Influence of drugs on vitamin D and calcium metabolism. Dermatoendocrinol 2012; 4(2): 158–166.
17. Gröber U, Spitz J, Reichrath J, et al. Vitamin D: Update 2013. From rickets prophylaxis to general preventive healthcare. Dermatoendocrinol 2013; 5(3): 331–347.
18. Horowitz RI, Freeman PR. Three novel prevention, diagnostic and treatment option for COVID-19 urgently necessitating controlled randomised trials. Med Hypotheses 2020; 143: 109851.
19. Ikeagwulonu RC, Etukudoh NS, Obeta MU, Mgbecheta CU. Does vitamin D serum levels affect the risk of covid 19 and its clinical outcome? A review of literature. EAS J Med Surg 2020; 2(6): 146–151.
20. Jain AJ, Chaurasia R, Sengar NS, et al. Analysis of vitamin D level among asymptomatic and critically ill COVID-19 patients and its correlation with inflammatory markers. Sci Reports 2020; 10: 20191.
21. Kaufman HW, Niles JK, Kroll MH, et al. SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levels. PLoS One 2020; 15(9): e0239252.
22. Khorasanizadeh MH, Eskian M, Camargo CA, et al. Vitamin D and immune system. In: Mahmoudi M, Rezaei N (Eds). Nutrition and Immunity. Cham: Springer 2019.
23. Kunisawa J, Kiyono H. Vitamin-mediated regulation of intestinal immunity. Front Immunol 2013; 4: 189.
24. Lee C, Verma R, Buyn S, et al. Structural specifities of cell surface β-glucan polysaccharides determine commensal yeast mediated immuno-modulatory activities. Nat Commun 2021; 12(1): 3611.
25. Leaf DE, Ginde AA. Vitamin D3 to treat COVID-19. Different disease, same answer. JAMA 2021; 325(11): 1047–1048.
26. Meltzer DO, Best TJ, Zhang H, et al. Association of vitamin D status and other clinical characteristics with COVID-19 test results. JAMA Open Netw 2020; 3(9): e2019722.
27. Mohan M, Cherian JJ, Sharma A. Exploring links between vitamin D deficiency and COVID-19. PLoS Pathog 2020; 16(9): e1008874.
28. Mousavi SE, Amini H, Heydarpour P, et al. Air pollution, environmental chemicals, and smoking may trigger vitamin D deficiency: Evidence and potential mechanisms. Environ Int 2019; 122: 67–90.
29. Pintheiro MM, Fabbri A, Infante M. Cytokine storm modulation in COVID-19: a proposed role for vitamin D and DPP-4 inhibitor combination therapy (VIDPP-4i). Immunotherapy 2021; 13(9): 753–765.
30. Raha S, Mallick R, Basak S, Duttaroy AK. Is copper beneficial for COVID-19 patients? Med Hypotheses 2020; 142:109814.
31. Richter J, Vetvicka V, Richterova S, Kral V. Nutrition and immunity during pandemic viral Infection. J Nutr Food Sci Tech 2021; 2(1): 1–6.
32. Rubin R. Sorting out wheather vitamin D deficiency raises COVID-19 risk. JAMA 2021; 325(4): 329–330.
33. Touvier M, Deschasaux M, Montourcy M, et al. Determinants of vitamin D status in caucasian adults: influence of sun exposure, dietary intake, sociografic, lifestyle, anthropometric, and genetic factors. J. Invest Dermatol 2015; 135(2): 378–388.
34. Vetvicka V, Vannucci L, Sima P, Richter J. Beta glucan: Supplement or drug? from laboratory to clinical trials. Molecules 2019; 24(7): 1251.
35. Wacker M, Holick M. Sunlight and vitamin D. A global perspecive for health. Dermato-Endocrinology 2013; 5(1): 51–108.
36. Weir EK, Thenappan T, Bhargava M, Chen Y. Does vitamin D deficiency increase the severity of COVID-19? Clin Med 2020; 20(4): e107–e108.
37. Wicinski M, Adamkiewicz D, Adamkiewicz M, et al. Impact of vitamin D on physical efficiency and exercise performance-A review. Nutrients 2019; 11(11): 20192826.
38. de la Puente Yagüe M, Collado Yurrita L, Ciudad Cabañas MJ, Cuadrado Cenzual MA. Role of vitamin D in athlets and their performance: current concepts and new trends. Nutrients 2020; 12(2): 579.
39. Yisak H, Ewunetei A, Kefale B, et al. Effects of vitamin D on Covid-19 infection and prognosis: A systematic review. Risk Manag Healthc Policy 2021; 14: 31–38.
40. Zittermann A, Pilz S, Hoffmann H, Marz W. Vitamin D and airway infections: a European perspective. Eur J Med Res 2016; 21: 14.
41. Public Health Ontario 2021: Association of vitamin D status with COVID-19 incidence and outcomes, and health equity considerations. Public Health Ontario 2021. Queens Printer for Ontario 2021, ASP oahpp.ca 1–31.
Labels
General practitioner for children and adolescents General practitioner for adultsArticle was published in
General Practitioner
2023 Issue 1
Most read in this issue
- Non-neoplastic portal vein thrombosis
- Pain and neuromodulation – new possibilities
- Health literacy and patient autonomy
- Using health literacy communication strategies in clinical practice